Amorepacific

Amorepacific is a South Korean company founded in 1945 that specializes in the manufacturing and marketing of personal care products and cosmetics. The company offers a diverse range of products, including creams, toners, fluids, ampoules, cleansing items, eye care solutions, serums, sun care products, body care items, and special care treatments. In addition to its product offerings, Amorepacific provides skin evaluation services that assess skin conditions such as dryness, pollution exposure, and sensitivity. The company is committed to innovation and sustainability within the beauty and wellness sectors, making it a significant player in the global cosmetics market.

Bae Dong-hyun

President

Giovanni Valentini

CEO

Mike Kim

Investment Principal

15 past transactions

Two Slash For

Seed Round in 2024
Two Slash For is a beauty brand that offers a wide variety of cosmetic products online.

Tata’s Natural Alchemy

Acquisition in 2022
Tata's Natural Alchemy, LLC manufactures natural antiaging skincare products. The company provides antiaging serums, aromatherapy products, body care products, cleansers, lip care products, moisturizers and toners, masks, eye creams, and exfoliators. It also sells its products online

Your Name Here

Series A in 2021
Your Name Here is a fashion designer specializing in women's clothing, offering a diverse range of products that include t-shirts, jeans, outerwear, tops, bottoms, skirts, and accessories. The brand focuses on providing a three-dimensional fit that caters to the female form, ensuring both style and comfort. By prioritizing trendy designs, Your Name Here aims to empower women with fashionable and well-fitting apparel.

Milk Makeup

Venture Round in 2019
Milk Makeup LLC, founded in 2014 and headquartered in New York, specializes in manufacturing and selling a diverse range of cosmetics, including products for eyes, lips, face, skin, and nails. The company also offers various beauty accessories such as tattoo stamps, eyelash curlers, and tweezers, along with skincare items that are cruelty-free, paraben-free, and 100% vegan. Milk Makeup focuses on high-tech, on-the-go formulas, catering to consumers seeking convenience in their beauty routines. Its products are available for purchase online as well as in physical retail locations. As a subsidiary of Milk Studios, LLC, Milk Makeup aims to provide innovative beauty solutions that incorporate vitamins, minerals, and antioxidants to support skin health.

Toun28

Series A in 2019
Toun28 is a manufacturer and supplier of organic skincare products focused on promoting healthy changes in skin conditions. The company leverages big data to analyze customers' facial conditions alongside climate and environmental factors, allowing for the formulation of personalized skincare solutions. These customized products are offered through a monthly subscription service, enabling customers to effectively manage their skincare routines based on their individual needs.

BlockOdyssey

Seed Round in 2018
BlockOdyssey Inc. is a technology start-up based in Daejeon, South Korea, specializing in blockchain-based distribution management solutions. The company focuses on providing industry-specific applications such as anti-counterfeiting systems, data storage, and currency exchange. Its primary offering is a blockchain platform that integrates logistics and distribution history management, enabling reliable data sharing among businesses. This platform employs advanced authentication methods, including digital signature QR codes, to ensure the security and integrity of logistics information. BlockOdyssey has garnered investment from prominent companies, including Asia's largest cosmetic firm, and is actively collaborating with pharmaceutical companies in France to enhance its offerings.

HairFit

Seed Round in 2017
HairFit is a virtual hairstyling application that utilizes advanced technologies such as facial recognition, big data, virtual reality, and augmented reality. The app allows users to explore and visualize various hairstyles tailored to their unique features, providing a natural and interactive hairstyling experience. By analyzing users' facial characteristics, HairFit enables individuals to try on different looks and styles virtually, enhancing their ability to make informed decisions about hairstyling options. This innovative approach caters to those seeking to experiment with their appearance without the commitment of actual hair changes.

Elastagen

Series B in 2016
Elastagen is a clinical stage medical company focused on developing products derived from the human protein tropoelastin, which is essential for the elasticity and resilience of various tissues in the body, including skin and blood vessels. The company has created a synthetic version of elastin that mimics the natural protein found in humans. Its advanced product pipeline targets applications in skin rejuvenation, scar remodeling, and tissue repair. With injectable synthetic human elastin and chemically cross-linked tropoelastin for aesthetic uses, Elastagen aims to help patients maintain skin elasticity and suppleness. Founded after acquiring intellectual property rights to elastin technology developed by Professor Weiss at the University of Sydney, Elastagen has successfully secured funding from prominent life science venture capital firms and expanded its operations to include production in Europe and clinical activities in the UK.

WayWearable

Venture Round in 2015
WayWearable, Inc. is a skincare technology company based in Seoul, South Korea, founded in 2014. It has developed the WAY device, a portable skincare companion that resembles a compact powder case and integrates advanced biometric and environmental sensors. This device works in conjunction with a companion app to provide personalized skincare recommendations tailored to individual needs, having been created with input from dermatologists. WayWearable aims to enhance women's health and well-being by facilitating smarter skincare decisions. The company is actively working to bring its innovative technology to market, having recently joined Sparklabs, a prominent business accelerator in Asia, and launched an Indiegogo campaign to support production efforts. Looking ahead, WayWearable plans to expand its product line, focusing on creating targeted skincare solutions that address the unique concerns of women while offering deeper insights into maintaining a healthy lifestyle.

Tria Beauty

Private Equity Round in 2013
TRIA Beauty, Inc. specializes in developing and selling light-based medical devices designed for consumer use in skincare and beauty treatments. The company's primary offerings include a hand-held diode laser device for permanent hair removal, a Skin Perfecting Blue Light device targeting acne-causing bacteria, a Skin Rejuvenating Laser for anti-aging, and an Age-Defying Eye Wrinkle Correcting Laser aimed at reducing fine lines around the eyes. These products leverage advanced light technology, typically used in professional dermatological treatments, allowing users to achieve salon-quality results at home. TRIA Beauty markets its products through its e-commerce platform and various indirect sales channels, including television, retail locations, and physician offices. Founded in 2003 and headquartered in Dublin, California, TRIA Beauty serves customers across multiple countries, including the United States, Japan, and several European nations. The company previously operated under the name SpectraGenics, Inc. before rebranding in 2008.

Brickell Biotech

Series B in 2013
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell’s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®.

Obalon Therapeutics

Venture Round in 2012
Obalon Therapeutics, Inc. is a medical device company based in Carlsbad, California, that specializes in developing and commercializing innovative solutions for obesity treatment. The company is known for its Obalon Balloon System, which includes a swallowable capsule containing an inflatable balloon, a navigation console for tracking balloon placement, a semi-automated inflation device, and a disposable gas canister. This system aims to assist patients in achieving weight loss through a non-surgical approach. Founded in 2008, Obalon emphasizes collaboration with clinicians and a commitment to rigorous testing to ensure safety and performance in its products. As of early 2020, the company operated three retail treatment centers in California, reflecting its focus on providing accessible solutions for individuals struggling with obesity.

Neothetics

Series C in 2012
Neothetics, Inc. was a clinical-stage specialty pharmaceutical company focused on developing therapeutics for the aesthetic market. Founded in 2007 and based in San Diego, California, the company aimed to address cosmetic concerns through innovative treatments. Its primary product candidate, LIPO-202, was an injectable formulation designed to reduce localized fat deposits, specifically targeting submental fat under the chin and central abdominal bulging in non-obese individuals. In January 2018, Neothetics was acquired by Evofem Biosciences in a reverse merger transaction, marking a significant shift in its business trajectory. The company was previously known as Lipothera, Inc. before rebranding in August 2014.

Evofem Biosciences

Series C in 2012
Evofem Biosciences is a biopharmaceutical company based in San Diego, California, focused on addressing unmet needs in women's sexual and reproductive health. The company has developed Phexxi, the first and only hormone-free prescription vaginal gel approved in the United States for pregnancy prevention. In addition to Phexxi, Evofem is also working on EVO100, a vaginal pH regulator aimed at preventing the urogenital transmission of Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. Through its innovative products, Evofem Biosciences aims to enhance reproductive health care options for women.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.